… the mRNA-1273 SARS-CoV-2 vaccine encoding a stabilized prefusion spike trimer, S-2P.
Experience with the mRNA platform for other candidate vaccines … clinical vaccine candidate in …

… of the immune responses elicited by SARS-CoV-2 mRNA vaccines, built on the data from …
mRNA vaccine uptake/biodistribution and the innate immune response to mRNA vaccines are …

… However, there remain significant challenges in the development and testing of vaccines as
… of mRNA-based SARS-CoV-2 vaccines and the current status of the mRNA-1273 vaccine. …

… We conclude that the plasma neutralizing activity elicited by mRNA vaccination or natural …
that are found in emerging variants of SARS-CoV-2. Vaccine-elicited monoclonal antibodies …

… mRNA-1273, an mRNA vaccine that encodes a SARS-CoV-2 spike protein that is stabilized
in the prefusion conformation. Here we show that mRNA-… D614G mutant 2 SARS-CoV-2 as …

… The Coronavirus Efficacy (COVE) phase 3 trial … mRNA-1273 vaccine in preventing SARS-CoV-2
infection. An independent data and safety monitoring board determined that the vaccine …

… As an emerging technology, mRNA vaccine is widely … SARS-CoV-2 vaccines, specifically
mRNA vaccines, focusing on the challenges of developing mRNA vaccines against SARS-CoV-…

… vaccination and/or SARS-CoV-2 infection fare against emerging virus variants, we assembled
a cohort of mRNA-vaccinated … We found that mRNA vaccines induced high titres of virus-…

… complications of Coronavirus Disease 2019 (… by mRNA vaccines 12 . Furthermore, a rapid
anamnestic response might be generated upon subsequent exposure to VOCs by vaccination-…

… antigen to design effective vaccines against SARS-CoV-2, indicating great potential of
RBD-based mRNA vaccine for mitigation of the COVID-19 pandemic and possible SARS-related …